Gastroesophageal Junction Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating emibetuzumab in combination with ramucirumab in various advanced cancers, with completed status and results poste…
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis [Phase 2]
Phase 2 trial evaluating ramucirumab plus paclitaxel as second-line therapy for metastatic gastric or gastroesophageal junction adenocarcino…
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer [Phase 2]
Phase 2 trial updating epacadostat plus pembrolizumab in metastatic or unresectable gastroesophageal junction or gastric cancer (completed; …
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer. [Phase 2, Phase 3]
A clinical trial comparing QL1604 plus nab-paclitaxel versus nab-paclitaxel alone in advanced gastric or gastroesophageal junction adenocarc…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial update evaluating andecaliximab with mFOLFOX6 as first-line therapy for advanced gastric or gastroesophageal junction adenocar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) [Phase 3]
Phase 3 trial evaluating pembrolizumab as first-line monotherapy and in combination for advanced gastric or gastroesophageal junction adenoc…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction [Phase 3]
Phase 3 trial evaluating apatinib in combination with concurrent neoadjuvant chemoradiotherapy for gastroesophageal junction adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction [Phase 2]
Phase 2 clinical trial evaluating apatinib plus concurrent neoadjuvant chemoradiotherapy for locally advanced HER-2 negative gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 2]
Phase 2 trial evaluating conversion therapy with sintilimab plus CAPOX in unresectable locally advanced or limited metastatic stomach/EGJ ad…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating tripletrumab plus SOX as first-line treatment for gastric cancer and gastroesophageal junction adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating a modified DCF regimen (docetaxel, cisplatin, and fluorouracil) in unresectable or metastatic gastric and gastroe…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating avelumab plus paclitaxel or ramucirumab as second-line therapy for gastroesophageal junction adenocarcinoma and sto…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating metronomic capecitabine and docetaxel as second-line chemotherapy for advanced gastric/gastroesophageal ju…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers [Phase 2]
Phase 2 trial assessing CRS-207 with pembrolizumab in gastric, gastroesophageal junction, and esophageal adenocarcinomas; study terminated w…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial update for ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer [Phase 2]
Phase 2 trial of ramucirumab with paclitaxel in gastric cancer completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) [Phase 3]
Phase 3 trial comparing pembrolizumab to paclitaxel in advanced gastric/GEJ adenocarcinoma after platinum/fluoropyrimidine showed completed …
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) [Phase 3]
Phase 3 trial of avelumab in third-line gastric cancer has completed; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Siewert Type I-II: CT, PET-CT, EUS Sensitivity/Specificity for the Assessment of Lymph Node Metastases
Completed clinical trial comparing CT, PET-CT, and EUS for detecting lymph node metastases in Siewert Type I-II esophageal/gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer [Phase 3]
Phase 3 trial of ramucirumab with capecitabine and cisplatin in metastatic gastric/GEJ adenocarcinoma completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C [Phase 1]
Phase 1 trial update of MLN0264 in previously treated Asian patients with advanced gastrointestinal carcinoma, including gastric and gastroe…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 3]
Amgen's Phase 3 trial evaluating rilotumumab for MET-positive gastric/GEJ adenocarcinoma was terminated, indicating the study did not procee…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
This document reports the results update of a Phase 2 trial comparing paclitaxel with or without cixutumumab as second-line therapy for meta…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Gastric Microperfusion in Patients Undergoing Gastroesophageal Resections
The update reports the completion of a clinical trial evaluating gastric microperfusion in patients undergoing gastroesophageal resections.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining panitumumab with docetaxel and cisplatin as first-line therapy for advanced ga…